Skip to Content

Essilorluxottica

EL: XPAR (FRA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€445.13LdzrFhbtlcqv

Essilorluxottica's Growth Slows in Q4 and Margin Progression Weakens in 2H; Shares Slightly Rich

We are maintaining our fair value estimate for wide-moat Essilorluxottica as the company reported full-year results largely in line with our estimates. Revenue came in 2% higher than our estimates, but operating profit was bang in line as adjusted profitability progression was a bit slower than expected (16.8%, up 70 basis points from 2021 and lower than our 17.2% estimate). Shares look slightly overvalued at current levels.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of EL so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center